BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 14, 2016
View Archived Issues
Aurigene announces the exercise of Curis' option for CA-327
Read More
WK-0202 shows protective effects against Adriamycin-induced cardiotoxicity
Read More
Daiichi Sankyo and Dana-Farber Cancer Institute enter preclinical research collaboration
Read More
Ablynx discloses second extension of collaboration with Merck & Co. subsidiary
Read More
Transgene enters collaboration with Merck KGaA and Pfizer
Read More
First-line ribociclib plus letrozole highly effective in phase III breast cancer trial
Read More
Immunovaccine reports results from phase I trial of DPX-RSV
Read More
ContraVir reports interim data from phase IIa trial of CMX-157 in HBV
Read More
Aptose receives response from FDA regarding clinical hold for phase Ib trial of APTO-253
Read More
NIH grants support to Recombinetics' development of swine models of Alzheimer's and NF2
Read More
TG Therapeutics files amended protocol with FDA for GENUINE phase III trial
Read More
Regeneron and Ocular Therapeutix to develop sustained-release aflibercept for ophthalmic indications
Read More
Shenyang Sunshine Pharmaceutical patents PHD2 inhibitors
Read More
Sichuan Kelun Pharmaceutical Research discloses anticancer agents
Read More
SIWA-318 inhibits tumor metastasis in breast cancer mouse model
Read More
ZMapp beneficial but not superior to standard care in PREVAIL II Ebola virus disease trial
Read More
McGill University and Florida Institute of Technology describe OXER1 antagonists
Read More
Human Stem Cells Institute licenses Neovasculgen to ArtGen for development in the U.S. and Canada
Read More
Vertex Pharmaceuticals develops PAR2 antagonists
Read More
Anvyl presents deuterated etifoxine analogs
Read More
Sunovion submits NDA for SUN-101/Eflow
Read More
Novel mutation in GRK1 gene may cause Oguchi disease
Read More
Limited activity seen with single-agent buparlisib treatment in CNS lymphoma trial
Read More
Aslan enters collaboration with Nanyang Technological University to develop modybodies
Read More
Oncogenex Pharmaceuticals reports results for phase III ENSPIRIT trial of custirsen
Read More
Novel KERA mutations associated with cornea plana
Read More
AC-0010 shows promising anticancer activity in NSCLC patients
Read More